GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Japanese
Top Page
About Us
R&D
Investor Relations
Contact Us
[Japanese]
Latest Information
Read more
12/10/2018
Information
GNI Group Ltd. Ranked 351st on Deloitte Technology Fast 500 Asia Pacific 2018, A Ranking Program of Fastest-Growing Technology Companies
10/25/2018
Information
Cullgen files 2 patents and presents at the Targeted Protein Degradation Summit at Boston, USA
IR News
Read more
About Us
Message
Business Model/Business Overview
Board of Directors
Company Overview
Office
Corporate governance
R&D
R&D
Products/Pipeline
艾思瑞
®
(Etuary)
F351
F573
Tamibarotene
Discovery Research
Interstitial Lung Disease
Liver disease area
Chronic kidney disease (CKD or CRD)
Research publications
Investor Relations
Investor Relations
IR News
Financial Reports
Conference Material/Convocation Letter
TSE Filings
Bulletin Board
Information
Message
Business Model
Stock Quote
